Table 1:
Disease | Abbrev. | Inheritance | Host gene | Repeat motif | Location | Somatic instability | LOF | RBP sequestration | AUG-initiated protein GOF | RAN translation | Other |
---|---|---|---|---|---|---|---|---|---|---|---|
Unverricht-Lundborg disease | EPM1 | AR | CSTB | CCCCGCCCCGCG | promoter | + | |||||
Baratela-Scott syndrome | BSS | AR | XYLT1 | CGG | promoter/5’ UTR | + | + | ||||
Glutaminase deficiency | GAD | AR | GLS | CAG | 5’ UTR | + | + | ||||
Spinocerebellar ataxia type 12 | SCA12 | AD | PPP2R2B | CAG | 5’ UTR | + | |||||
Fragile XE syndrome | FRAXE | XL | AFF2 | CCG | 5’ UTR | + | + | ||||
Jacobsen syndrome | FRA11B | AD | CBL2 | CCG | 5’ UTR | + a | |||||
Intellectual disability, associated with fragile site FRA2A | FRA2A | AD | AFF3 | CGG | 5’ UTR | + | + | ||||
Intellectual disability, associated with fragile site FRA12A | FRA12A | AD | DIP2B | CGG | 5’ UTR | + | |||||
Fragile X syndrome | FXS | XL | FMR1 | CGG | 5’ UTR | + | + | ||||
Fragile X-associated primary ovarian insufficiency | FXPOI | XL | FMR1 | CGG | 5’ UTR | + | + | ||||
Fragile X-associated tremor/ataxia syndrome | FXTAS | XL | FMR1 | CGG | 5’ UTR | + | + | + | |||
Neuronal intranuclear inclusion disease | NIID | AD | NOTCH2NLC | CGG | 5’ UTR | ||||||
Oculopharyngodistal myopathy 1 | OPDM1 | AD | LRP12 | CGG | 5’ UTR | + | |||||
Oculopharyngodistal myopathy 2 | OPDM2 | AD | GIPC1 | CGG | 5’ UTR | ||||||
Oculopharyngeal myopathy with leukoencephalopathy | OPML | AD | LOC642361/NUTM2B-AS1 | CGG/CCG | lncRNA | + | |||||
Cerebellar ataxia, neuropathy, vestibular areflexia syndrome | CANVAS | AR | RFC1 | AAGGG | intron | ||||||
Spinocerebellar ataxia type 10 | SCA10 | AD | ATXN10 | ATTCT | intron | + | + | ||||
X-linked dystonia-parkinsonism | XDP | XL | TAF1 | CCCTCT | intron | + | + | ||||
Myotonic dystrophy type 2 | DM2 | AD | CNBP | CCTG | intron | + | + | + | |||
Autism spectrum disorder, associated with fragile site FRA7A | FRA7A | AD | ZNF713 | CGG | intron | + | + | ||||
Fuchs endothelial corneal dystrophy | FECD | AD | TCF4 | CTG | intron | + | + | + | |||
Friedreich’s ataxia | FA | AR | FXN | GAA | intron | + | + | ||||
Spinocerebellar ataxia type 36 | SCA36 | AD | NOP56 | GGCCTG | intron | + | + | ||||
C9ORF72 amyotrophic lateral sclerosis/frontotemporal dementia | C9 ALS/FTD | AD | C9ORF72 | GGGGCC | intron | + | + | + | + | ||
Spinocerebellar ataxia type 31 | SCA31 | AD | BEAN1/TK2 | TGGAA/TTCCA | intron | + | + | ||||
Familial adult myoclonic epilepsy 1 | FAME1 | AD | SAMD12 | TTTCA | intron | + | |||||
Familial adult myoclonic epilepsy 2 | FAME2 | AD | STARD7 | TTTCA | intron | ||||||
Familial adult myoclonic epilepsy 3 | FAME3 | AD | MARCH6 | TTTCA | intron | + | |||||
Familial adult myoclonic epilepsy 4 | FAME4 | AD | YEATS2 | TTTCA | intron | ||||||
Familial adult myoclonic epilepsy 6 | FAME6 | AD | TNRC6A | TTTCA | intron | ||||||
Familial adult myoclonic epilepsy 7 | FAME7 | AD | RAPGEF2 | TTTCA | intron | ||||||
Spinocerebellar ataxia type 37 | SCA37 | AD | DAB1 | TTTCA | intron | ||||||
Dentatorubral-pallidoluysian atrophy | DRPLA | AD | ATN1 | CAG | CDS | + | + | + | |||
Huntington’s disease | HD | AD | HTT | CAG | CDS | + | + | + | + | ||
Spinal and bulbar muscular atrophy | SBMA | XL | AR | CAG | CDS | + | + | + | |||
Spinocerebellar ataxia type 1 | SCA1 | AD | ATXN1 | CAG | CDS | + | + | + | |||
Spinocerebellar ataxia type 2 | SCA2 | AD | ATXN2 | CAG | CDS | + | + | + | |||
Spinocerebellar ataxia type 3 | SCA3 | AD | ATXN3 | CAG | CDS | + | + | + | |||
Spinocerebellar ataxia type 6 | SCA6 | AD | CACNA1A | CAG | CDS | + | |||||
Spinocerebellar ataxia type 7 | SCA7 | AD | ATXN7 | CAG | CDS | + | + | ||||
Spinocerebellar ataxia type 17 | SCA17 | AD | TBP | CAG | CDS | + | + | + | |||
Pseudoachondroplasia and multiple epiphyseal dysplasia | PSACH/MED | AD | COMP | GAC | CDS | + | + | ||||
Blepharophimosis, ptosis, and epicanthus inversus syndrome | BPES | AD | FOXL2 | GCN | CDS | + | |||||
Cleidocranial dysplasia | CCD | AD | RUNX2 | GCN | CDS | + | |||||
Congenital central hypoventilation syndrome | CCHS | AD | PHOX2B | GCN | CDS | + c | + | ||||
Hand-foot-genital syndrome | HFGS | AD | HOXA13 | GCN | CDS | + c | + | ||||
Holoprosencephaly 5 | HPE | AD | ZIC2 | GCN | CDS | + c | + | ||||
Oculopharyngeal muscular dystrophy | OPMD | AD | PABPN1 | GCN | CDS | + | + | ||||
Synpolydactyly 1 | SPD | AD | HOXD13 | GCN | CDS | + | |||||
X-linked hypopituitarism | XH | XL | SOX3 | GCN | CDS | + | |||||
X-linked intellectual disability b | XLID | XL | ARX | GCN | CDS | + c | + | ||||
Spinocerebellar ataxia type 8 | SCA8 | AD | ATXN8OS/ATXN8 | CTG/CAG | 3’ UTR/CDS | + | + | + | |||
Myotonic dystrophy type 1 | DM1 | AD | DMPK | CTG | 3’ UTR | + | + | + | |||
Huntington’s disease-like 2 | HDL2 | AD | JPH3 | CTG | 3’ UTR | + | + |
FRA11B expansion causes hypermethylation and is associated with chromosomal breakage and deletion of the telomeric end of 11q.271
Loss-of-function mutations in ARX are associated with a spectrum of clinical phenotypes, including X-linked infantile spasm syndrome, X-linked lissencephaly with ambiguous genitalia, X-linked myoclonic epilepsy and intellectual disability, Partington syndrome, Ohtahara syndrome, and Proud syndrome.272